230 results on '"Koutsoukos, Konstantinos"'
Search Results
2. Cardiovascular complications of ribociclib in breast cancer patients
3. Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer
4. Clinical perspectives of BET inhibition in ovarian cancer
5. The emerging role of BET inhibitors in breast cancer
6. Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium
7. Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy
8. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
9. Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
10. The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study
11. Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
12. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction.
13. Intravenous rituximab and oral cyclophosphamide for the treatment of cancer‑associated retinopathy in a patient with epithelial ovarian cancer: A case report
14. Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)
15. Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer
16. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction
17. Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis
18. Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
19. D4.6 REUSABLE MODEL & ANALYTICAL TOOLS: SOFTWARE PROTOTYPE 3
20. Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm
21. Optimal Time Interval Between Neoadjuvant Platinum-based Chemotherapy and Interval Debulking Surgery in High-grade Serous Ovarian Cancer
22. 2022-RA-1607-ESGO Optimal time interval between neoadjuvant platinum-based chemotherapy and interval debulking surgery
23. Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents
24. PolicyCLOUD D4.3 Reusable Model & Analytical Tools: Design and Open Specification 2
25. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG)
26. Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
27. SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition
28. Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
29. Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival
30. Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
31. Policy Cloud D4.4 REUSABLE MODEL & ANALYTICAL TOOLS: SOFTWARE PROTOTYPE 2
32. Mobile Anonymization and Pseudonymization of Structured Health Data for Research
33. Molecular testing for prostate cancer in Greek patients.
34. Emergency Health Protocols Supporting Health Data Exchange, Cloud Storage, and Indexing
35. SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
36. PolicyCloud D3.5 CLOUD INFRASTRUCTURE INCENTIVES MANAGEMENT AND DATA GOVERNANCE SOFTWARE PROTOTYPE 2
37. Pembrolizumab in Combination with Bevacizumab and Oral Cyclophosphamide in Heavily Pretreated Platinum-Resistant Ovarian Cancer
38. What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
39. ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
40. BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
41. Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
42. Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
43. D6.4 USE CASES IMPLEMENTATION & EXPERIMENTATION
44. MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
45. Neutrophil-to-Lymphocyte Ratio and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant Chemotherapy
46. Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
47. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
48. SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
49. Clinical perspectives of BET inhibition in ovarian cancer
50. MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.